Patients Book a Consult Pharmacists Order here

FreshLeaf Analytics H2 2021

The H2 2021 report represents FreshLeaf Analytics’ seventh market analysis, focusing on patients, products, and pricing within the Australian medicinal cannabis market.


Key highlights include:

In 2021, market growth is set to surpass expectations as the number of active patients approaches 100,000. By year’s end, revenue from product sales is projected to reach $230 million. Although the product count keeps rising, the growth rate of new products is decelerating. Meanwhile, the average monthly spend maintains its gradual decline, while the average daily dose increases.



Looking to invest in the rapidly growing medicinal cannabis industry? We collate in-depth analysis, industry news and expert insights to help you make informed investment decisions.

Contact for general info

Get in touch to receive general investment information via email.


Sign up to Investor Centre

Learn about Cannatrek investment opportunities.

Sign up

Login to Investor Portal

Login to the Cannatrek Investor Portal.